An Assessment of The Number of Chronic Lymphocytic Leukemia (CLL) Patients Eligible For Front-Line Treatment But Unsuitable For Full-Dose Fludarabine Across The European Union
    
      
    
Abstract
Authors
D Jeyakumaran A Kempel S Cote
D Jeyakumaran A Kempel S Cote
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now